EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondria‐derived vesicles: A promising and potential target for tumour therapy

Xueqiang Peng iD, Yu Gao, Jiaxing Liu, Xinxin Shi, Wei Li, Yingbo Ma, Xuexin Li iD, Hangyu Li iD

Clinical and Translational Medicine · 2025-05 · 15 (5)

DOI: 10.1002/ctm2.70320 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 12.05.2025. Verfasst von Xueqiang Peng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Mitochondria, Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Provincial Central Government Guiding Local Science, Technology Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria‐derived vesicles (MDVs) participate in early cellular defence mechanisms initiated in response to mitochondrial damage. They maintain mitochondrial quality control (MQC) by clearing damaged mitochondrial components, thereby ensuring the normal functioning of cellular processes. This process is crucial for cell survival and health, as mitochondria are the energy factories of cells, and their damage can cause cellular dysfunction and even death. Recent studies have shown that MDVs not only maintain mitochondrial health but also have a significant impact on tumour progression. MDVs selectively encapsulate and transport damaged mitochondrial proteins under oxidative stress and reduce the adverse effects of mitochondrial damage on cells, which may promote the survival and proliferation of tumour cells. Furthermore, it has been indicated that after cells experience mild stress, the number of MDVs significantly increases within 2–6 h, whereas mitophagy, a process of clearing damaged mitochondria, occurs 12–24 h later. This suggests that MDVs play a critical role in the early stress response of cells. Moreover, MDVs also have a significant role in intercellular communication, specifically in the tumour microenvironment. They can carry and transmit various bioactive molecules, such as proteins, nucleic acids, and lipids, which regulate tumour cell's growth, invasion, and metastasis. This intercellular communication may facilitate tumour spread and metastasis, making MDVs a potential therapeutic target. Advances in MDV research have identified novel biomarkers, clarified regulatory mechanisms, and provided evidence for clinical use. These breakthroughs pave the way for novel MDV‐targeted therapies, offering improved treatment alternatives for cancer patients. Further research can identify MDVs' role in tumour development and elucidate future cancer treatment horizons.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitochondriaNeoplasmsExtracellular VesiclesHumansTumor Microenvironment

Stichwörter der Autor:innen

mitochondria‐derived vesicletargettransport pathwaytumour progressiontumour therapy

Autor:innen und Institutionen

  • Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, China.
  • Group of Chronic Disease and Environmental Genomics, School of Public Health, China Medical University, Shenyang, China.
  • Shenyang Clinical Medical Research Center for Diagnosis, Treatment and Health Management of Early Digestive Cancer, Shenyang, China.
  • Department of General Surgery, The First Hospital of Anhui University of Science & Technology, Huainan, China.
  • Depatment of Hepatobiliary Surgery, Air Force Medical Center, Beijing, China.
  • Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Xueqiang Peng, Xuexin Li, Hangyu Li

Förderung

  • National Natural Science Foundation of China
  • Liaoning Provincial Central Government Guiding Local Science
  • Technology Development Funds
  • Science and Technology Projects of Shenyang
  • Support plan for young and middle-aged scientific and technological talents in Shenyang

Zitieren

APA

Peng, X., Gao, Y., Liu, J., Shi, X., Li, W., Ma, Y., Li, X., & Li, H. (2025). Mitochondria‐derived vesicles: A promising and potential target for tumour therapy. Clinical and Translational Medicine, 15(5). https://doi.org/10.1002/ctm2.70320

Vancouver

Peng X, Gao Y, Liu J, Shi X, Li W, Ma Y, et al. Mitochondria‐derived vesicles: A promising and potential target for tumour therapy. Clinical and Translational Medicine. 2025;15(5). doi:10.1002/ctm2.70320

BibTeX
@article{Peng2025,
  author = {Peng, Xueqiang and Gao, Yu and Liu, Jiaxing and Shi, Xinxin and Li, Wei and Ma, Yingbo and Li, Xuexin and Li, Hangyu},
  title = {Mitochondria‐derived vesicles: A promising and potential target for tumour therapy},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  volume = {15},
  number = {5},
  doi = {10.1002/ctm2.70320}
}
Kostenlos starten →